Fred Aslan

Insider Reports History

Location
San Diego, CA
Signature
/s/ Andrew Cronauer, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Fred Aslan:

Company Role Class Num Shares Value Price $ Report Date Ownership
Artiva Biotherapeutics, Inc. President and CEO, Director Common Stock 1,562,198 $6,248,792 $4.00 15 Feb 2026 Direct
Artiva Biotherapeutics, Inc. President and CEO, Director Employee Stock Option (Right to Buy) 0 12 Dec 2025 Direct

Insider Reports Filed by Fred Aslan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ARTV Artiva Biotherapeutics, Inc. 15 Feb 2026 2 -$58,400 4 President and CEO, Director 18 Feb 2026, 18:48
ARTV Artiva Biotherapeutics, Inc. 15 Dec 2025 1 -$19,122 4 President and CEO, Director 15 Dec 2025, 21:19
ARTV Artiva Biotherapeutics, Inc. 12 Dec 2025 7 $0 4 President and CEO, Director 12 Dec 2025, 19:19
ARTV Artiva Biotherapeutics, Inc. 15 Nov 2025 2 -$42,150 4 President and CEO, Director 17 Nov 2025, 20:37
ARTV Artiva Biotherapeutics, Inc. 17 Oct 2025 1 -$153,000 4 President and CEO, Director 17 Oct 2025, 20:44
ARTV Artiva Biotherapeutics, Inc. 15 May 2025 3 -$91,403 4 President and CEO, Director 18 Aug 2025, 20:15
ARTV Artiva Biotherapeutics, Inc. 05 Mar 2025 1 $0 4 President and CEO, Director 07 Mar 2025, 16:35
ARTV Artiva Biotherapeutics, Inc. 18 Jul 2024 2 $0 4 President and CEO, Director 22 Jul 2024, 20:18
ARTV Artiva Biotherapeutics, Inc. 18 Jul 2024 0 $0 3 President and CEO, Director 18 Jul 2024, 20:00